Longyi blood glucose test system - Taiwan Registration 63e6f84aa9c15a2221135eb828d00c52
Access comprehensive regulatory information for Longyi blood glucose test system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 63e6f84aa9c15a2221135eb828d00c52 and manufactured by Longsheng Pharmaceutical Co., Ltd.;; Taibo Technology Co., Ltd. five stock factory. The authorized representative in Taiwan is DRAGON PHARMACEUTICAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Taibo Technology Co., Ltd. five-stock factory, and 2 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
Quantitatively measure the amount of glucose in the blood.
A Clinical chemistry and clinical toxicology
A.1345 Glucose Test System
Domestic;; Contract manufacturing
Dates and Status
Jan 20, 2017
Nov 28, 2020
Jul 15, 2022
Cancellation Information
Logged out
ๆชๅฑๅปถ่้พๆ่
Longyi blood glucose test system
Taibo Technology Co., Ltd. five-stock factory
40856a5d717555f06006d0b1f530212a
2
Longyi blood glucose test system
Taibo Technology Co., Ltd. five-stock factory
d3ab31442de986d6077f83dc895ba08f
2

